Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Flortaucipir · Tauvid, T-807

Small molecule · Acts on aggregated tau (paired helical filament tau / neurofibrillary tangles) · developed by Eli Lilly And Company

Approved FDA
LLY Developer

What is Flortaucipir?

Flortaucipir F 18 is a radioactive PET imaging agent that binds to aggregated tau protein, including paired helical filament tau in neurofibrillary tangles. It is used to estimate the density and distribution of tau tangles in the brain of patients with cognitive impairment being evaluated for Alzheimer's disease.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Tauvid, T-807
Drug type
Small molecule
Targets
aggregated tau (paired helical filament tau / neurofibrillary tangles), monoamine oxidase-A (MAOA) (secondary target), monoamine oxidase-B (MAOB) (secondary target)
Mechanism
Acts on aggregated tau (paired helical filament tau / neurofibrillary tangles)
Therapy area
Neurology
Developer
Eli Lilly And Company (LLY)
FDA status
Approved as Tauvid, NDA212123 · FDA label
UNII
J09QS3Z3WB

✅ FDA-approved uses

From the indications section of the FDA label (version of Dec 30, 2025). Read the full label for the exact wording, limitations and safety information.

Conditions studied

Alzheimer Disease

More from Eli Lilly And Company

Sources

Updated Nov 1, 2026. Something wrong or missing? Report it on the LLY page.

Follow LLY, the company behind Flortaucipir

See LLY's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

LLY catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.